AIRLINK 74.00 Decreased By ▼ -0.25 (-0.34%)
BOP 5.14 Increased By ▲ 0.09 (1.78%)
CNERGY 4.55 Increased By ▲ 0.13 (2.94%)
DFML 37.15 Increased By ▲ 1.31 (3.66%)
DGKC 89.90 Increased By ▲ 1.90 (2.16%)
FCCL 22.40 Increased By ▲ 0.20 (0.9%)
FFBL 33.03 Increased By ▲ 0.31 (0.95%)
FFL 9.75 Decreased By ▼ -0.04 (-0.41%)
GGL 10.75 Decreased By ▼ -0.05 (-0.46%)
HBL 115.50 Decreased By ▼ -0.40 (-0.35%)
HUBC 137.10 Increased By ▲ 1.26 (0.93%)
HUMNL 9.95 Increased By ▲ 0.11 (1.12%)
KEL 4.60 Decreased By ▼ -0.01 (-0.22%)
KOSM 4.83 Increased By ▲ 0.17 (3.65%)
MLCF 39.75 Decreased By ▼ -0.13 (-0.33%)
OGDC 138.20 Increased By ▲ 0.30 (0.22%)
PAEL 27.00 Increased By ▲ 0.57 (2.16%)
PIAA 24.24 Decreased By ▼ -2.04 (-7.76%)
PIBTL 6.74 Decreased By ▼ -0.02 (-0.3%)
PPL 123.62 Increased By ▲ 0.72 (0.59%)
PRL 27.40 Increased By ▲ 0.71 (2.66%)
PTC 13.90 Decreased By ▼ -0.10 (-0.71%)
SEARL 61.75 Increased By ▲ 3.05 (5.2%)
SNGP 70.15 Decreased By ▼ -0.25 (-0.36%)
SSGC 10.52 Increased By ▲ 0.16 (1.54%)
TELE 8.57 Increased By ▲ 0.01 (0.12%)
TPLP 11.10 Decreased By ▼ -0.28 (-2.46%)
TRG 64.02 Decreased By ▼ -0.21 (-0.33%)
UNITY 26.76 Increased By ▲ 0.71 (2.73%)
WTL 1.38 No Change ▼ 0.00 (0%)
BR100 7,874 Increased By 36.2 (0.46%)
BR30 25,596 Increased By 136 (0.53%)
KSE100 75,342 Increased By 411.7 (0.55%)
KSE30 24,214 Increased By 68.6 (0.28%)

SAN FRANCISCO: Google said Friday it was banning online ads for unproven medical treatments including most stem cell and gene therapy.

"This new policy will prohibit ads selling treatments that have no established biomedical or scientific basis," Google policy adviser Adrienne Biddings said in a blog post.

Biddings said Google will "prohibit advertising for unproven or experimental medical techniques such as most stem cell therapy, cellular (non-stem) therapy and gene therapy."

Google will also ban "treatments that are rooted in basic scientific findings and preliminary clinical experience, but currently have insufficient formal clinical testing to justify widespread clinical use," she added.

The online giant said it made the decision due to "a rise in bad actors attempting to take advantage of individuals by offering untested, deceptive treatments."

The company said this was not an effort to diminish the importance of medical discoveries but maintained that "monitored, regulated clinical trials are the most reliable way to test and prove important medical advances."

Google said it took the action after consulting experts in the field and that its move was endorsed by the president of the International Society for Stem Cell Research, Deepak Srivastava.

In Google's statement, Srivastava was quoted as saying, "The premature marketing and commercialization of unproven stem cell products threatens public health, their confidence in biomedical research, and undermines the development of legitimate new therapies."

Online services have struggled to filter out misleading and deceptive content, including medical hoaxes, while remaining open platforms.

Earlier this year Facebook and Google-owned YouTube moved to reduce the spread of misleading health care claims after a media report showed the proliferation of bogus cancer cures on social media.

Facebook said it made changes as part of efforts to reduce the spread of misleading medical claims including from groups opposing the use of recommended vaccines.

A Wall Street Journal report, based on interviews with doctors, lawyers, privacy experts and others, found numerous false or misleading claims about cancer therapies online.

These included videos advocating the use of potentially dangerous cell-killing ointments, unverified dietary regimes, or unapproved  screening techniques.

 

Comments

Comments are closed.